Digestive system cancers
1-minute read
Follow the links below to find trusted information about digestive system cancers.
Last reviewed: May 2018
Need more information?
These trusted information partners have more on this topic.
Top results
Bowel cancer - Cancer Pathways
Call Bowel Cancer Australia on 1800 555 494 for information about bowel cancer or to speak to specialised bowel cancer nurses or visit www.bowelcanceraustralia.org
Read more on Cancer Council Victoria website
Pancreatic cancer fact sheet | Cancer Australia
An overview of pancreatic cancer including types, symptoms, risk factors, diagnosis, treatment and finding support.
Read more on Cancer Australia website
Pancreatic Cancer - Information, Treatment & Support - CanTeen
Pancreatic cancer is an uncommon condition that usually affects older people. Learn more about causes, diagnosis and treatments with CanTeen.
Read more on CanTeen website
Liver Cancer - Information, Treatment & Support - CanTeen
The liver is the largest organ in the body and cancers of this organ develop into carcinomas. Learn more about causes and treatments of liver cancer with CanTeen.
Read more on CanTeen website
Bowel Cancer (Staging)
Most bowel cancers develop in the large bowel (colon) or rectum. The cancer usually develops from tiny growths called polyps, however, only a small number of polyps become cancerous.
Read more on Diagnostic Imaging Pathways website
Bowel cancer - myDr.com.au
Bowel cancer - the second most common type of cancer affecting both men and women in Australia - is cancer that starts in the large bowel (colon) or rectum.
Read more on myDr website
Bowel cancer screening and prevention | Health and wellbeing | Queensland Government
Changes to your bowels can indicate a number of health conditions including cancer. If you notice changes to your regular bowel habits, especially if you notice blood in your stools you should consult your doctor. Under the National Bowel Cancer Screening Program Australians turning 50, 55, 60 or 65 will be automatically offered a free bowel cancer screening kit to help detect any abnormalities early so that further investigation or treatment can occur.
Read more on Queensland Health website
Bowel Cancer - Information, Treatment & Support - CanTeen
Bowel cancer, or colorectal cancer, is the second most common cancer in both men and women. Learn more about causes, diagnosis and treatments with CanTeen.
Read more on CanTeen website
Liver cancer - Cancer Pathways
Qualified cancer nurses can answer your questions about the effects of cancer, explain what will happen during treatment or link you to support groups and other community resources.
Read more on Cancer Council Victoria website
Stomach Cancer - Information, Treatment & Support - CanTeen
The stomach is the organ that regulates your digestion and cancers can include carcinomas and lymphomas. Learn more about causes and treatment of stomach cancer with CanTeen.
Read more on CanTeen website
Top results
Surgery for resolving symptoms associated with malignant bowel obstruction in advanced gynaecological and gastrointestinal cancers | Cochrane
Read more on Cochrane (Australasian Centre) website
Endoscopic mucosal resection for early stomach cancer | Cochrane
Read more on Cochrane (Australasian Centre) website
Drain after gastrectomy for gastric cancer | Cochrane
Read more on Cochrane (Australasian Centre) website
Pancreatic Cancer (Suspected and Staging)
Home IMAGING PATHWAYS Gastrointestinal Pancreatic and Biliary System Pancreatic Cancer (Suspected and Staging)
Read more on Diagnostic Imaging Pathways website
Colorectal Cancer (Suspected)
This pathway provides guidance on the investigation of patients with symptoms and / or signs of suspected colorectal cancer.
Read more on Diagnostic Imaging Pathways website
Colorectal Cancer (Staging)
This pathway provides guidance on imaging patients with proven colorectal cancer, indicating how imaging helps determine management.
Read more on Diagnostic Imaging Pathways website
Omentoplasty for oesophagogastrostomy after oesophagectomy | Cochrane
Oesophagectomy followed by oesophagogastrostomy, in which an anastomosis between the residual oesophagus and the stomach substitute is made, remains the standard surgery for patients with oesophageal cancer. Whichever surgical procedure is chosen, that is, transthoracic oesophagectomy (TTE) with direct visualisation of the thoracic oesophagus or transhiatal oesophagectomy (THE) with avoidance of a thoracic incision, postoperative anastomotic leakage causes considerable morbidity and mortality. Omentoplasty, in which the omentum is used to wrap the anastomosis, has been recommended by some researchers to prevent postoperative anastomotic leakageone of the most serious complications of oesophagectomy followed by oesophagogastrostomy for patients with oesophageal cancer. This updated systematic review, including 633 participants in three randomised controlled trials, suggests that omentoplasty could reduce the incidence of anastomotic leakage and the duration of hospital stay after operation. Although the difference in anastomotic leakage was significant only among patients undergoing THE, the risk ratios of omentoplasty for THE and TTE were similar. In addition, omentoplasty does not appear to increase or decrease hospital mortality nor the incidence of postoperative complications, such as anastomotic stricture, pulmonary and cardiac complications, infection, vocal cord palsy and perijejunostomy leakage. Additional clinical trials are needed to investigate the influences of omentoplasty on the incidence of anastomotic leakage and anastomotic stricture, long-term survival, duration of hospital stay and quality of life after oesophagectomy and oesophagogastrostomy when different surgical approaches are used.
Read more on Cochrane (Australasian Centre) website
Daily intake of 1 gr dietary calcium may have moderate protective effect on development of colorectal adenomatous polyps | Cochrane
Daily intake of 1 gr dietary calcium may have moderate protective effect on development of colorectal adenomatous polyps
Read more on Cochrane (Australasian Centre) website
Effect of molecular-targeted therapy on the progress and survival of people in the late stages of stomach cancer | Cochrane
Effect of molecular-targeted therapy on the progress and survival of people in the late stages of stomach cancer
Read more on Cochrane (Australasian Centre) website
Screening for oesophageal cancer | Cochrane
Oesophageal cancer is a common cause of cancer related death in the world. The prognosis in the advanced stages is unfavourable, but the early oesophageal cancers are asymptomatic and curable, and usually go undetected until they have spread beyond the oesophageal wall. Endoscopy with iodine staining or cytologic examination are two common screening tests for early oesophageal cancer. These screening tests were started in the 1970s, but the true benefit is inconsistent and is uncertain due to lead-time bias, which is the amount of time by which the diagnosis is advanced by the screening procedure; and length-time bias, where screening is more likely to detect slow-growing disease rather than altering the person's duration of life. This review intended to determine the efficacy of the two screening tests for oesophageal cancer. We identified 3482 studies but none were RCTs of screening. Several non-comparative studies showed that the screening tests may increase the incidence of reported oesophageal cancer and improve the survival results after a screening test, but these results could indicate bias rather than a true causative effect. Therefore, there is a strong need for randomised controlled trials (RCTs), especially long-term RCTs, to determine the efficacy, cost-effectiveness, and any adverse effects of screening for oesophageal cancer.
Read more on Cochrane (Australasian Centre) website
